AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
184.85
+1.25 (0.68%)
Mar 23, 2026, 3:10 PM EDT - Market open

AstraZeneca Revenue

In the year 2025, AstraZeneca had annual revenue of $58.74B with 8.63% growth. AstraZeneca had revenue of $15.50B in the quarter ending December 31, 2025, with 4.11% growth.

Revenue (ttm)
$58.74B
Revenue Growth
+8.63%
P/S Ratio
9.73
Revenue / Employee
$617,655
Employees
95,100
Market Cap
573.38B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202558.74B4.67B8.63%
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 201924.38B2.29B10.38%
Dec 31, 201822.09B-375.00M-1.67%
Dec 31, 201722.47B-537.00M-2.33%
Dec 31, 201623.00B-1.71B-6.90%
Dec 31, 201524.71B-1.84B-6.93%
Dec 31, 201426.55B741.00M2.87%
Dec 31, 201325.81B-2.17B-7.75%
Dec 31, 201227.97B-5.62B-16.72%
Dec 31, 201133.59B322.00M0.97%
Dec 31, 201033.27B465.00M1.42%
Dec 31, 200932.80B1.20B3.81%
Dec 31, 200831.60B2.04B6.91%
Dec 31, 200729.56B3.08B11.65%
Dec 31, 200626.48B2.53B10.54%
Dec 31, 200523.95B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Johnson & Johnson94.19B
Eli Lilly and Company65.18B
Merck & Co.65.01B
Pfizer62.58B
AbbVie61.16B
Novartis AG56.67B
Sanofi54.85B
Novo Nordisk48.59B
Revenue Rankings